LEVETIRACETAM DEXCEL 500

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Beli sekarang

Download Risalah maklumat (PIL)
22-11-2021
Download Laporan Penilaian Awam (PAR)
06-02-2020

Bahan aktif:

LEVETIRACETAM

Boleh didapati daripada:

DEXCEL PHARMA TECHNOLOGIES LTD

Kod ATC:

N03AX14

Borang farmaseutikal:

TABLETS

Komposisi:

LEVETIRACETAM 500 MG

Laluan pentadbiran:

PER OS

Jenis preskripsi:

Required

Dikeluarkan oleh:

DEXCEL LTD, ISRAEL

Kumpulan terapeutik:

LEVETIRACETAM

Kawasan terapeutik:

LEVETIRACETAM

Tanda-tanda terapeutik:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Tarikh kebenaran:

2018-03-31

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Arab 22-11-2021
Risalah maklumat Risalah maklumat Ibrani 09-10-2023

Cari amaran yang berkaitan dengan produk ini